Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Century Therapeutics (IPSC) Tax Provisions (2022 - 2024)

Historic Tax Provisions for Century Therapeutics (IPSC) over the last 3 years, with Q4 2024 value amounting to $1.8 million.

  • Century Therapeutics' Tax Provisions rose 30508.08% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year decrease of 493.63%. This contributed to the annual value of $1.8 million for FY2024, which is 498.94% down from last year.
  • Latest data reveals that Century Therapeutics reported Tax Provisions of $1.8 million as of Q4 2024, which was up 30508.08% from -$8000.0 recorded in Q3 2024.
  • In the past 5 years, Century Therapeutics' Tax Provisions ranged from a high of $1.8 million in Q4 2024 and a low of -$866000.0 during Q4 2023
  • For the 3-year period, Century Therapeutics' Tax Provisions averaged around $313833.3, with its median value being $23500.0 (2022).
  • Over the last 5 years, Century Therapeutics' Tax Provisions had its largest YoY gain of 745000.0% in 2023, and its largest YoY loss of 280625.0% in 2023.
  • Over the past 3 years, Century Therapeutics' Tax Provisions (Quarter) stood at $32000.0 in 2022, then plummeted by 2806.25% to -$866000.0 in 2023, then soared by 305.08% to $1.8 million in 2024.
  • Its last three reported values are $1.8 million in Q4 2024, -$8000.0 for Q3 2024, and $22000.0 during Q2 2024.